Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures.

Stokstad T, Sørhaug S, Amundsen T, Grønberg BH.

BMC Health Serv Res. 2019 Sep 18;19(1):679. doi: 10.1186/s12913-019-4517-z.

2.

Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.

Pettersen K, Andersen S, Degen S, Tadini V, Grosjean J, Hatakeyama S, Tesfahun AN, Moestue S, Kim J, Nonstad U, Romundstad PR, Skorpen F, Sørhaug S, Amundsen T, Grønberg BH, Strasser F, Stephens N, Hoem D, Molven A, Kaasa S, Fearon K, Jacobi C, Bjørkøy G.

Sci Rep. 2017 May 17;7(1):2046. doi: 10.1038/s41598-017-02088-2.

3.

Measurement of health-related quality of life during chemotherapy - the importance of timing.

Kristensen A, Solheim TS, Amundsen T, Hjelde HH, Kaasa S, Sørhaug S, Grønberg BH.

Acta Oncol. 2017 May;56(5):737-745. doi: 10.1080/0284186X.2017.1279748. Epub 2017 Jan 24.

PMID:
28117614
4.

Medical complexity and time to lung cancer treatment - a three-year retrospective chart review.

Stokstad T, Sørhaug S, Amundsen T, Grønberg BH.

BMC Health Serv Res. 2017 Jan 17;17(1):45. doi: 10.1186/s12913-016-1952-y.

5.

New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.

Johns N, Stretch C, Tan BH, Solheim TS, Sørhaug S, Stephens NA, Gioulbasanis I, Skipworth RJ, Deans DA, Vigano A, Ross JA, Bathe OF, Tremblay ML, Kaasa S, Strasser F, Gagnon B, Baracos VE, Damaraju S, Fearon KC.

J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):122-130. doi: 10.1002/jcsm.12138. Epub 2016 Aug 5.

6.

A new removable airway stent.

Amundsen T, Sørhaug S, Leira HO, Tyvold SS, Langø T, Hammer T, Manstad-Hulaas F, Mattsson E.

Eur Clin Respir J. 2016 Sep 6;3:30010. doi: 10.3402/ecrj.v3.30010. eCollection 2016.

7.

Learning endobronchial ultrasound transbronchial needle aspiration - a 6-year experience at a single institution.

Sørhaug S, Hjelde H, Hatlen P, Leira HO, Salarinejad M, Nesvik B, Hollund R, Nesgård K, Nordhaug DO, Amundsen T.

Clin Respir J. 2018 Jan;12(1):40-47. doi: 10.1111/crj.12475. Epub 2016 Apr 1.

PMID:
26954393
8.

PET/MR brain imaging: evaluation of clinical UTE-based attenuation correction.

Aasheim LB, Karlberg A, Goa PE, Håberg A, Sørhaug S, Fagerli UM, Eikenes L.

Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1439-46. doi: 10.1007/s00259-015-3060-3. Epub 2015 Apr 22.

PMID:
25900276
9.

[Occupational lung cancer in Sør-Trøndelag county].

Slåstad S, Leira HL, Aas O, Amundsen T, Sørhaug S, Sundstrøm S, Grønberg BH, Hilt B.

Tidsskr Nor Laegeforen. 2014 Oct 28;134(20):1943-7. doi: 10.4045/tidsskr.13.0900. eCollection 2014 Oct 28. Norwegian.

10.

Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer.

Stene GB, Helbostad JL, Amundsen T, Sørhaug S, Hjelde H, Kaasa S, Grønberg BH.

Acta Oncol. 2015 Mar;54(3):340-8. doi: 10.3109/0284186X.2014.953259. Epub 2014 Sep 16.

PMID:
25225010
11.

Release of neuroendocrine products in the pulmonary circulation during intermittent hypoxia in isolated rat lung.

Sørhaug S, Steinshamn S, Munkvold B, Waldum HL.

Respir Physiol Neurobiol. 2008 Jun 30;162(1):1-7. doi: 10.1016/j.resp.2008.02.014. Epub 2008 Mar 12.

PMID:
18468494
12.

Carbon monoxide levels experienced by heavy smokers impair aerobic capacity and cardiac contractility and induce pathological hypertrophy.

Bye A, Sørhaug S, Ceci M, Høydal MA, Stølen T, Heinrich G, Tjønna AE, Najjar SM, Nilsen OG, Catalucci D, Grimaldi S, Contu R, Steinshamn S, Condorelli G, Smith GL, Ellingsen O, Waldum H, Wisløff U.

Inhal Toxicol. 2008 May;20(7):635-46. doi: 10.1080/08958370701883821 .

PMID:
18464052
13.

Expression of neuroendocrine markers in non-small cell lung cancer.

Sørhaug S, Steinshamn S, Haaverstad R, Nordrum IS, Martinsen TC, Waldum HL.

APMIS. 2007 Feb;115(2):152-63.

PMID:
17295682
14.

Chronic inhalation of carbon monoxide: effects on the respiratory and cardiovascular system at doses corresponding to tobacco smoking.

Sørhaug S, Steinshamn S, Nilsen OG, Waldum HL.

Toxicology. 2006 Dec 7;228(2-3):280-90. Epub 2006 Sep 29.

PMID:
17056171
15.

Increased serum levels of chromogranin A in male smokers with airway obstruction.

Sørhaug S, Langhammer A, Waldum HL, Hveem K, Steinshamn S.

Eur Respir J. 2006 Sep;28(3):542-8. Epub 2006 May 17.

16.

Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC.

Sørhaug S, Steinshamn SL, Waldum HL.

Lung Cancer. 2005 Apr;48(1):137-40.

PMID:
15777981
17.

Dysregulated secretoglobin expression in human lung cancers.

Sjödin A, Guo D, Sørhaug S, Bjermer L, Henriksson R, Hedman H.

Lung Cancer. 2003 Jul;41(1):49-56.

PMID:
12826312

Supplemental Content

Loading ...
Support Center